AKT1 and cancer: Therefore, inactivation of the PI3K/Akt pathway should be effective as a specific chemotherapy against malignant tumors [20,21] because of lower expression of Akt in the surrounding normal tissue, and this type of chemotherapy should not have strong side effects.